RTW INVESTMENTS LP 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:49 am Sale | 2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 0 0.000% | -2,067,824 (Position Closed) | Filing |
| 2023-02-14 10:10 am Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 2,067,824 6.900% | -118,500 (-5.42%) | Filing |
| 2022-02-14 08:43 am Purchase | 2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 2,186,324 7.900% | 673,651 (+44.53%) | Filing |
| 2021-02-12 09:38 am Purchase | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 1,512,673 9.310% | 256,816 (+20.45%) | Filing |
| 2020-06-11 08:54 am Purchase | 2020-06-01 | 13G | Relmada Therapeutics, Inc. RLMD | RTW INVESTMENTS LP | 1,255,857 8.260% | 1,255,857 (New Position) | Filing |